ociclib 98% CAS NO 571190-30-2
cy571190-30-2
origin: China
packaging: Package: 25kg
MOQ: 25
China {title} with High-Quality, Leading {title} Manufacturers & Suppliers, find {title} Factory & Exporters.
Palbociclib (also known as compound number PD-0332991) is an experimental drug for the treatment of breast cancer being developed by Pfizer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6. Pabixi cloth Chinese alias: 6-acetyl-8-cyclopentyl-5-methyl-2-[[5-(1-piperazine) -2-pyridyl] amino]-pyridino [2,3-d] pyrimidine-7(8H) -one; 6-acetyl-8-cyclopentyl-5-methyl-2-[[5-(piperazine-1-yl) pyridine-2-yl] amino]-8H-pyrimidine [2,3-d] pyrimidine-7-one; English Name: palbociclib English alias: PD332991; PD 0332991; Palbociclib; 6-acetyl-8-cyclopentyl-5-methyl-2-[(5-piperazin-1-ylpyridin-2-yl) amino] pyrido [2,3-d] pyrimidin-7-one; CAS: 571190-30-2 Molecular formula: C24H29N7O2 Molecular weight: 447.53300 Precise quality: 447.23800 PSA:105.04000 LogP:3.43260 Physicochemical properties Density: 1.313g/cm3 Melting point: 200ºC Boiling point: 711.5ºC at 760 mmHg Flash point: 384.1 ºC Refractive index: 1.647 http://www.chenyichem.com
*Your email address will not be published. Required fields are marked.